December 12, 2024 Kigali, Rwanda and San Francisco, USA

Bio Usawa has a singular focus: to build the manufacturing capacity required to make and supply high quality, effective and affordable antibody-based biosimilars for ophthalmic, cancer, autoimmune and infectious diseases. We are applying our 100+ years of combined experience in the industry in close partnership with governments, agencies, educators and health professionals to tap into a talented domestic workforce for making powerful biomedicines in Africa, by Africans, for Africans and beyond.

Click here to learn more about our Company's recent successes and download our new White Paper on Regulatory Approaches to Biosimilars in Africa.